We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+20.33%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$600M
AUM Growth
+$79.5M
(+15%)
Cap. Flow
+$21.8M
Cap. Flow
% of AUM
3.64%
Top 10 Holdings %
Top 10 Hldgs %
21.67%
Holding
133
New
15
Increased
59
Reduced
31
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merit Medical Systems
MMSI
|
+$6.18M |
| 2 |
Privia Health
PRVA
|
+$5.98M |
| 3 |
CONMED
CNMD
|
+$5.55M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$5.01M |
| 5 |
MoonLake Immunotherapeutics
MLTX
|
+$4.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$12.1M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$11.6M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$6.67M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
+$5.53M |
| 5 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$5.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.97% |
| 2 | Industrials | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCM
1
DELISTED
R1 RCM Inc. Common Stock
RCM
| $14.9M | 2.49% |
809,194
-140,000
| -15% | -$2.27M |
|
2
Evolent Health
EVH
$654M
| $14.8M | 2.47% |
488,142
-3,000
| -0.6% | -$97K |
|
|
3
Privia Health
PRVA
$3.39B
| $13.2M | 2.21% |
506,622
+226,310
| +81% | +$5.98M |
|
|
APLS
4
DELISTED
Apellis Pharmaceuticals
APLS
| $13.1M | 2.19% |
143,859
-28,631
| -17% | -$2.47M |
|
5
RadNet
RDNT
$4.89B
| $13M | 2.17% |
398,634
+85,701
| +27% | +$2.49M |
|
6
BioMarin Pharmaceuticals
BMRN
$11.5B
| $12.9M | 2.15% |
148,448
+24,018
| +19% | +$2.26M |
|
7
Option Care Health
OPCH
$3.41B
| $12.7M | 2.11% |
390,000
+91,500
| +31% | +$2.76M |
|
8
Icon
ICLR
$13.1B
| $12M | 2% |
47,972
-2,566
| -5% | -$545K |
|
9
AtriCure
ATRC
$1.77B
| $11.8M | 1.97% |
239,532
+80,000
| +50% | +$3.69M |
|
10
HealthEquity
HQY
$8.17B
| $11.6M | 1.93% |
183,375
| – | – |
|
11
Eli Lilly
LLY
$1.05T
| $11.1M | 1.86% |
23,765
| – | – |
|
12
UnitedHealth
UNH
$387B
| $11M | 1.84% |
22,925
-3,150
| -12% | -$1.54M |
|
13
Insmed
INSM
$23.5B
| $10.9M | 1.82% |
517,841
+1,749
| +0.3% | +$33.2K |
|
14
Mineralys Therapeutics
MLYS
$2.39B
| $10.5M | 1.75% |
614,713
+1,480
| +0.2% | +$22.1K |
|
15
Prothena Corp
PRTA
$453M
| $10.4M | 1.73% |
151,848
+29,098
| +24% | +$1.88M |
|
16
Johnson & Johnson
JNJ
$609B
| $10.3M | 1.71% |
62,100
| – | – |
|
17
Treace Medical Concepts
TMCI
$279M
| $9.71M | 1.62% |
379,443
+13,000
| +4% | +$336K |
|
18
PTC Therapeutics
PTCT
$6.52B
| $9.42M | 1.57% |
231,696
+5,130
| +2% | +$251K |
|
|
19
MoonLake Immunotherapeutics
MLTX
$1.64B
| $9.41M | 1.57% |
+184,590
| New | +$4.97M |
|
|
FOLD
20
DELISTED
Amicus Therapeutics
FOLD
| $9.17M | 1.53% |
729,924
+209,942
| +40% | +$2.49M |
|
|
NARI
21
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $8.9M | 1.48% |
153,043
| – | – |
|
|
BPMC
22
DELISTED
Blueprint Medicines
BPMC
| $8.65M | 1.44% |
136,837
+14,937
| +12% | +$812K |
|
23
ARS Pharmaceuticals
SPRY
$695M
| $8.41M | 1.4% |
1,255,640
+462,053
| +58% | +$3.08M |
|
24
Amylyx Pharmaceuticals
AMLX
$1.97B
| $8.35M | 1.39% |
387,310
+144,910
| +60% | +$3.91M |
|
25
Lantheus
LNTH
$7B
| $8.28M | 1.38% |
98,687
-19,000
| -16% | -$1.7M |
|
Similar funds
RIP
CCM
LFWA
FWA
CF
WIM
MW
AFC
Sectoral Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Sectoral Asset Management held 133 positions worth $600M, up 15% from $520M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Sectoral Asset Management deployed $21.8M of net new capital in Q2 2023, opening 15 new positions and adding to 59 existing holdings. Its largest new stake was Merit Medical Systems: 76,000 shares worth $6.36M.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Industrials.
On the sell side, the largest reduction was Shockwave Medical, Inc. Common Stock, an estimated $12.1M trimmed.
- Sectoral Asset Management's largest Q2 2023 buy was Merit Medical Systems: 76,000 shares worth $6.36M.
- Sectoral Asset Management added most to Privia Health in Q2 2023, an estimated $5.98M increase.
- Sectoral Asset Management's biggest Q2 2023 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $12.1M.
- Sectoral Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $11.6M.
- Sectoral Asset Management's ten largest holdings make up 22% of its $600M portfolio in Q2 2023.
- Sectoral Asset Management opened 15 new positions and closed 12 in Q2 2023.
- Sectoral Asset Management's portfolio value rose 15% quarter-over-quarter to $600M.
Based on Sectoral Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.